The Education and Scientific Program Committees have been hard at work putting together an excellent...March 4, 2021 - March 7, 2021
The EURAPAG 2021 congress will focus on children and adolescent gynecological problems. The program ...June 9, 2021 - June 12, 2021
The ISSWSH Fall Course is organized annually to provide an evidence-based foundation for clinicians ...October 7, 2021 - October 10, 2021
The SMSNA strives to promote, encourage and support the highest standards of practice, research, edu...October 21, 2021 - October 24, 2021
This will be the 22nd World Meeting of the International Society for Sexual MedicineNovember 15, 2021 - November 17, 2021
IUGA Meetings & Educational Programs are developed with the mission to advance urogynecological ...December 8, 2021 - December 11, 2021
Status Plus, with offices in the US and Europe, focuses on providing high-end management services to professional medical associations. Since our inception in 1992, we have obtained great experience and impeccable ethics in managing (inter)national non-profit associations, and we have a proven global track record in the successful planning and execution of numerous conferences, symposia, meetings and events around the world. We have extensive expertise in the fields of gynecology and urology and in the multidisciplinary field of sexual medicine/health.
As members of several scientific societies (including board positions) we have worked with many AMC’s over the years. Some are no more than glorified meeting planners, however Status Plus breaks from that in their ability to work wth leadership, provide guidance for long term planning as well as advice for short term success…
Status Plus’ top-notch professionals play a role in all aspects of our society, from involvement with our Board and committees, to providing excellent meeting management services and IT solutions, to meeting our members’ needs. They provide us with an infrastructure that poises us to grow our membership and programs and excel in fulfilling our mission for years to come.
In over 30 years of experience within the pharmaceutical industry I have never come across a more efficient and effective interface between industry and Scientific Societies. This goes well beyond excellent symposium organization into identifying creative solutions for provision of funding in this era of increasingly exacting regulatory and budgetary constraints.